Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page displays the ClinicalTrials.gov record for a completed Phase 2 study of tislelizumab combined with fruquintinib, including study results, eligibility criteria, locations, and supporting documents.
    Difference
    59%
    Check dated 2026-11-07T12:27:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer shows site revision v3.8.0 instead of v3.7.2; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T13:14:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the page, announcing a transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T16:39:24.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T16:24:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1, while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:42:20.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating access to the study record is blocked. This reflects an error condition rather than an update to the study data or page structure.
    Difference
    19%
    Check dated 2026-09-19T18:45:51.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.